"Founded in 1998, we are a research-intensive organization whose chief goals are to improve the health and wellness of American Indians and other Indigenous peoples through research, service, education and philanthropy. We are American Indian-led, and are a 501(c)(3) tax-exempt organization. With funding principally from NIH and CDC, we have considerable experience with cardiovascular epidemiology and intervention, cancer epidemiology, tobacco policy and control, smoking genetics, environmental health, and ethnographic research. We specialize in health disparities, the social determinants of health, asset-based approaches, randomized trials conduct and fidelity, and mentorship. We use both quantitative and qualitative research approaches."

During the past decade, Black Hills Clinical Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Black Hills Clinical Research Center" #1 sponsor was "Regado Biosciences, Inc." with 2 trials, followed by "Accumetrics, Inc." with 1 trials sponsored, "ActivBiotics" with 1 trials sponsored, "Anthera Pharmaceuticals" with 1 trials sponsored and "Black Hills Center for American Indian Health" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Black Hills Clinical Research Center" #1 collaborator was "Cheyenne River Sioux Tribe" with 1 trials as a collaborator, "Cheyenne River Sioux Tribe Telephone Authority" with 1 trials as a collaborator, "Missouri Breaks Industries Research, Inc." with 1 trials as a collaborator, "NuMedics, Inc." with 1 trials as a collaborator and "University of Colorado, Denver" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Black Hills Clinical Research Center" are "Coronary Artery Disease" (2 trials), "Coronary Artery Disease (CAD)" (2 trials), "Hypertension" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Black Hills Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Black Hills Clinical Research Center" are "Drug" (8 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "REG1" (2 trials), "Unfractionated Heparin" (2 trials), "A-002" (1 trials), "Chronic disease management Web-based software" (1 trials) and "Clopidogrel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Black Hills Clinical Research Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Black Hills Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Black Hills Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Black Hills Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".